K19719                      KO                                     

collagen type II alpha
ko04151  PI3K-Akt signaling pathway
ko04510  Focal adhesion
ko04512  ECM-receptor interaction
ko04974  Protein digestion and absorption
ko05165  Human papillomavirus infection
H00445  Osteoarthritis with mild chondrodysplasia
H00476  Multiple epiphyseal dysplasia
H00519  Spondyloepiphyseal dysplasia congenita
H00520  Type II collagenopathies
H00805  Vitreoretinal degeneration
H01526  Legg-Calve-Perthes Disease
H01529  Avascular necrosis of femoral head
H01709  Glucocorticoid-induced osteonecrosis
H02066  Achondrogenesis type II
H02070  Kniest dysplasia
H02071  Czech dysplasia
H02072  Stickler syndrome
H02187  Spondyloepimetaphyseal dysplasia
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04151 PI3K-Akt signaling pathway
    K19719  COL2A; collagen type II alpha
  09133 Signaling molecules and interaction
   04512 ECM-receptor interaction
    K19719  COL2A; collagen type II alpha
 09140 Cellular Processes
  09144 Cellular community - eukaryotes
   04510 Focal adhesion
    K19719  COL2A; collagen type II alpha
 09150 Organismal Systems
  09154 Digestive system
   04974 Protein digestion and absorption
    K19719  COL2A; collagen type II alpha
 09160 Human Diseases
  09172 Infectious disease: viral
   05165 Human papillomavirus infection
    K19719  COL2A; collagen type II alpha
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   00536 Glycosaminoglycan binding proteins
    K19719  COL2A; collagen type II alpha
Glycosaminoglycan binding proteins [BR:ko00536]
 Heparan sulfate / Heparin
  Extracellular matrix molecules
   K19719  COL2A; collagen type II alpha
Other DBs
GO: 0030020
HSA: 1280(COL2A1)
PTR: 451860(COL2A1)
PPS: 100983139(COL2A1)
GGO: 101127576(COL2A1)
PON: 100433193(COL2A1)
NLE: 100588525(COL2A1)
MCC: 704851(COL2A1)
MCF: 102134921(COL2A1)
CSAB: 103238216(COL2A1)
RRO: 104654840(COL2A1)
RBB: 108515958(COL2A1)
CJC: 100400909(COL2A1)
SBQ: 101041402(COL2A1)
MMU: 12824(Col2a1)
MCAL: 110310133(Col2a1)
MPAH: 110335075(Col2a1)
RNO: 25412(Col2a1)
MUN: 110560093(Col2a1)
CGE: 100755037(Col2a1)
NGI: 103740626(Col2a1)
HGL: 101707672(Col2a1)
CCAN: 109691615(Col2a1)
OCU: 100009005(COL2A1)
TUP: 102470303(COL2A1)
CFA: 102152155 403826(COL2A1)
VVP: 112921081(COL2A1)
AML: 100474711(COL2A1)
UMR: 103675428(COL2A1)
UAH: 113257484(COL2A1)
ORO: 101370480(COL2A1)
ELK: 111157855
FCA: 101087493(COL2A1)
PTG: 102956312(COL2A1)
PPAD: 109249029(COL2A1)
AJU: 106969351(COL2A1)
BTA: 407142(COL2A1)
BOM: 102284180(COL2A1)
BIU: 109559169(COL2A1)
BBUB: 102403678(COL2A1)
CHX: 100860743(COL2A1)
OAS: 100196905(COL2A1)
SSC: 397323(COL2A1)
CFR: 102516074(COL2A1)
CDK: 105103802(COL2A1)
LVE: 103078299(COL2A1)
OOR: 101276952(COL2A1)
DLE: 111174067(COL2A1)
PCAD: 102984074(COL2A1)
ECB: 791241(COL2A1)
EPZ: 103546826(COL2A1)
EAI: 106836837(COL2A1)
MYB: 102248763 102254720(COL2A1)
MYD: 102768294(COL2A1)
MNA: 107528223(COL2A1)
HAI: 109372512(COL2A1)
DRO: 112318365(COL2A1)
PALE: 102894333(COL2A1)
RAY: 107499897(COL2A1)
MJV: 108392454(COL2A1)
LAV: 100675826(COL2A1)
TMU: 101343281
MDO: 100027887
SHR: 100915177(COL2A1)
PCW: 110201505(COL2A1)
OAA: 100091569(COL2A1) 114807425
GGA: 395069(COL2A1)
MGP: 100540311
CJO: 107306964(COL2A1)
NMEL: 110390877(COL2A1)
APLA: 106014712(COL2A1)
ACYG: 106049583(COL2A1)
TGU: 100219722(COL2A1)
LSR: 110480541(COL2A1)
GFR: 102031754(COL2A1) 102034431
PHI: 102111968(COL2A1)
PMAJ: 107198731(COL2A1)
CCAE: 111940513(COL2A1)
ETL: 114073615
FPG: 101919991(COL2A1)
FCH: 102059900(COL2A1)
CLV: 102092442(COL2A1)
EGZ: 104126835
NNI: 104017542(COL2A1)
ASN: 102371324(COL2A1)
AMJ: 102576638(COL2A1)
PSS: 102455782
CMY: 102932287(COL2A1)
CPIC: 101949909(COL2A1)
ACS: 100553016(col2a1)
PVT: 110071756(COL2A1)
PBI: 103059733(COL2A1)
PMUR: 107288503(COL2A1)
PMUA: 114586408(COL2A1)
GJA: 107120677
XLA: 397738(col2a1.L) 397739(col2a1.S)
XTR: 394828(col2a1)
NPR: 108800103(COL2A1)
DRE: 503730(col2a1b) 562496(col2a1a)
IPU: 108265655(col2a1)
PHYP: 113527853
OLA: 100529192 100682394(col2a1a)
KMR: 108231621(col2a1b) 108232082(col2a1a)
LCM: 102345734 102359526(COL2A1)
CMK: 103189017(col1a2) 103189947(col2a1)
BFO: 118432715
CIN: 619229(fcol1)
SPU: 115917878 373267(COLP1alpha) 575353 583083(clmdn)
DPE: 6597673
MDE: 101889347
LCQ: 111684368
AAG: 110678066
AALB: 109421144
AME: 410038
BIM: 100743696
BTER: 100649253
CCAL: 108622864
OBB: 114872707
SOC: 105208111
MPHA: 105837322
AEC: 105154648
ACEP: 105622491
PBAR: 105432212
VEM: 105564766
HST: 105190388
DQU: 106750023
CFO: 105250620
LHU: 105673720
PGC: 109851614
OBO: 105285658
PCF: 106791787
NVI: 100120054
CSOL: 105362561
TCA: 660112
DPA: 109540705
NVL: 108568888
BMOR: 101746136
BMAN: 114253068
PMAC: 106712876
PRAP: 110999882
HAW: 110375333
TNL: 113496840
API: 100164192
DNX: 107169123
RMD: 113551888
BTAB: 109038179
CLEC: 106669954
ZNE: 110840376
FCD: 110856657
TUT: 107368669
CRG: 105325218
MYI: 110443072
OBI: 106868320
EGL: EGR_01301
NVE: 5521252
HMG: 100199754(HT1) 100211987(col2) 100212826(HT3)
AQU: 100634948
MNG: MNEG_1869
BCA: BCE_4868
BNC: BCN_4635
BCER: BCK_11550
BTT: HD73_5035
DAE: Dtox_3124
PSEH: XF36_06695
PAUT: Pdca_28680
RXY: Rxyl_2445
 » show all
Gordon MK, Hahn RA
Cell Tissue Res 339:247-57 (2010)
Muller S, Soder S, Oliveira AM, Inwards CY, Aigner T
Type II collagen as specific marker for mesenchymal chondrosarcomas compared to other small cell sarcomas of the skeleton.
Mod Pathol 18:1088-94 (2005)
Su MW, Lee B, Ramirez F, Machado M, Horton W
Nucleotide sequence of the full length cDNA encoding for human type II procollagen.
Nucleic Acids Res 17:9473 (1989)

DBGET integrated database retrieval system